A non-significant increase in the number of IgM+IgD+-expressing CD19+B220+CD5+CD1d+ Bregs was further detected in the blood of patients with MASLD and mice with MASLD (Fig. S8C, D). Here, CD1D is linked to metabolic dysfunction-associated steatotic liver disease.